Column Group IV GP, LP — SEC insider filings

SEC reporting owner CIK 1796356. 29 insider filings on record with FilingPulse; latest filed 2026-09-08.

Transaction summary — filings shown

Covers all 29 filings on record, filed 2022-01-26 to 2026-09-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Eikon Therapeutics, Inc. (EIKN)10% owner24 legs · 2,206,960 sh · $39,150,725—14
NGM BIOPHARMACEUTICALS INC (NGM)10% owner2362 legs · 3,690,481 sh · $27,605,175—14
RAPT Therapeutics, Inc. (RAPT)10% owner48 legs · 1,278,450 sh · $13,686,784—4

Insider filings — Column Group IV GP, LP

FiledFormIssuerReported transactionsSource
2026-09-084Eikon Therapeutics, Inc. (EIKN)
jointly with Column Group IV-A, LP, Column Group IV, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim, Svennilson Peter
Purchase (P): 89,200 @ $11.56EDGAR
2026-02-094Eikon Therapeutics, Inc. (EIKN)
jointly with Column Group IV-A, LP, Column Group IV, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim, Svennilson Peter
Conversion (C): 1,296,629 · Conversion (C): 1,403,568 · Conversion (C): 110,928 · Conversion (C): 44,249 · Conversion (C): 47,898 · Conversion (C): 3,785 · +11 moreEDGAR
2024-12-234RAPT Therapeutics, Inc. (RAPT)
jointly with COLUMN GROUP II, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC
Other (J): 1,352,008 · Other (J): 1,599,417 · Other (J): 1,352,008 (derivative) · Other (J): 1,599,417 (derivative)EDGAR
2024-04-084NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, COLUMN GROUP III GP, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Disposition to issuer (D): 949,862 · Disposition to issuer (D): 2,650,177 · Disposition to issuer (D): 90,442 · Disposition to issuer (D): 11,103,333 · Disposition to issuer (D): 858,035 · Disposition to issuer (D): 968,990 · +8 moreEDGAR
2023-11-174NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 16,791 @ $0.71 · Purchase (P): 5,840 @ $0.62EDGAR
2023-02-014NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 7,542 @ $5.00 · Purchase (P): 176,730 @ $5.00EDGAR
2023-01-254NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 9,900 @ $5.00EDGAR
2023-01-234NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 37,639 @ $5.00 · Purchase (P): 500 @ $5.00EDGAR
2023-01-174NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 5,378 @ $4.95EDGAR
2023-01-124NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 100,070 @ $4.84 · Purchase (P): 209,000 @ $4.76EDGAR
2022-12-144NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 300 @ $4.98EDGAR
2022-11-234NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 35,997 @ $5.00 · Purchase (P): 4,330 @ $5.00EDGAR
2022-11-074NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 104,090 @ $4.99 · Purchase (P): 35,058 @ $4.72EDGAR
2022-10-314NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 76,877 @ $4.86EDGAR
2022-10-274NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 51,046 @ $4.75 · Purchase (P): 72,774 @ $4.85EDGAR
2022-06-134NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC
Purchase (P): 951,684 @ $13.50 · Purchase (P): 32,477 @ $13.50EDGAR
2022-06-064NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC
Purchase (P): 33,071 @ $13.03 · Purchase (P): 1,129 @ $13.03EDGAR
2022-06-024NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC
Purchase (P): 59,766 @ $13.47 · Purchase (P): 2,040 @ $13.47 · Purchase (P): 88,964 @ $13.45 · Purchase (P): 3,036 @ $13.45EDGAR
2022-05-314NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC
Purchase (P): 19,534 @ $13.49 · Purchase (P): 667 @ $13.49 · Purchase (P): 2,621 @ $13.45 · Purchase (P): 89 @ $13.45EDGAR
2022-05-274RAPT Therapeutics, Inc. (RAPT)
jointly with COLUMN GROUP II, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC
Purchase (P): 1,837 @ $12.45 · Purchase (P): 63 @ $12.45EDGAR
2022-05-264NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC
Purchase (P): 17,240 @ $13.37 · Purchase (P): 588 @ $13.37 · Purchase (P): 41,863 @ $13.43 · Purchase (P): 1,429 @ $13.43EDGAR
2022-05-254RAPT Therapeutics, Inc. (RAPT)
jointly with COLUMN GROUP II, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC
Purchase (P): 9,898 @ $12.50 · Purchase (P): 338 @ $12.50 · Purchase (P): 15,776 @ $12.00 · Purchase (P): 538 @ $12.00EDGAR
2022-05-234NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC
Purchase (P): 19,984 @ $13.25 · Purchase (P): 682 @ $13.25 · Purchase (P): 18,406 @ $13.48 · Purchase (P): 628 @ $13.48EDGAR
2022-05-194NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC
Purchase (P): 86,110 @ $13.42 · Purchase (P): 2,939 @ $13.42 · Purchase (P): 60,583 @ $13.20 · Purchase (P): 2,067 @ $13.20EDGAR
2022-05-174NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC
Purchase (P): 125,096 · Purchase (P): 4,269 · Purchase (P): 32,072 @ $12.90 · Purchase (P): 1,094 @ $12.90EDGAR
2022-05-134NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC
Purchase (P): 77,866 @ $11.23 · Purchase (P): 2,657 @ $11.23 · Purchase (P): 2,564 @ $11.85 · Purchase (P): 88 @ $11.85 · Purchase (P): 79,945 @ $11.62 · Purchase (P): 2,728 @ $11.62 · +2 moreEDGAR
2022-05-124RAPT Therapeutics, Inc. (RAPT)
jointly with COLUMN GROUP II, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC
Purchase (P): 1,208,750 @ $10.67 · Purchase (P): 41,250 @ $10.67EDGAR
2022-05-114NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC
Purchase (P): 80,430 @ $10.79 · Purchase (P): 2,745 @ $10.79 · Purchase (P): 30,233 @ $11.36 · Purchase (P): 1,032 @ $11.36EDGAR
2022-01-264NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC
Purchase (P): 241,750 · Purchase (P): 8,250 · Purchase (P): 579,910 · Purchase (P): 19,791EDGAR

FilingPulse's Form 4 archive currently extends back to 2022-01-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1796356 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs